Piper Sandler Delivers Record Q1 Revenues on Debt Capital Markets and Healthcare Strength
PIPR•Piper Sandler reported record Q1 revenues driven by outsized Debt Capital Markets advisory performance and strong Healthcare and Medtech advisory fees. Bank M&A slowdown on larger transactions offset by increased small-deal volume, while equity and technology M&A face volatility-driven caution and unsustainable market share levels.
1. Q1 Financial Highlights
Piper Sandler posted record Q1 revenues, led by a standout Debt Capital Markets advisory unit and robust Healthcare and Medtech advisory fees. Non-M&A businesses including restructuring and private capital advisory also delivered steady contributions.
2. M&A Activity Trends
Large bank M&A transactions slowed relative to prior pace, while smaller deals sustained activity. Equity capital markets saw outsized market share gains, and Technology M&A showed growth but faces pressure from lower valuations and AI disruption concerns.
3. Outlook and Risks
Advisory fees are projected to decline sequentially as macro volatility creates an air pocket in sponsor deal launches. Interest rate volatility is complicating bank hedging strategies, and Q1 market share gains in capital markets may not be repeatable in Q2.
